People of color continue to be underrepresented in clinical trials. Together, Pfizer and Tigerlily Foundation created the HEAL (Health Equity Advocacy and Leadership) workshops to better understand the breast cancer journey for women of color and foster inclusivity in clinical trials.
Watch the video and learn more about the solutions uncovered:
"At Pfizer, our purpose is breakthroughs that change patients’ lives—all patients. We are committed to improving health outcomes for patients everywhere, including traditionally underserved and underrepresented communities such as women of color. From medical grants aimed at addressing health disparities, to policy-related initiatives, to educational resources for patients and healthcare professionals, Pfizer prioritizes partnering with Patient Advocacy Groups and large professional organizations to address the greatest challenges patients face and remove barriers to equitable care for all. We are grateful for the opportunity to join the #InclusionPledge and continue our efforts to collaborate with Tigerlily and many other stakeholders to meet the urgent and dynamic needs of breast cancer patients."
– Emma Andrews
Vice President, Global Patient Advocacy Lead